ASO Visual Abstract: Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma
Ann Surg Oncol
.
2025 Dec;32(13):9685-9686.
doi: 10.1245/s10434-025-18507-y.
Authors
Neha Shafique
#
1
,
Mohammad Saad Farooq
2
,
Valentina Mattfeld
3
,
Gracia Maria Vargas
1
,
Xiaowei Xu
4
,
Lynn Schuchter
5
,
Ravi Amaravadi
5
,
Tara Mitchell
5
,
John Miura
1
,
Giorgos Karakousis
1
Affiliations
1
Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA.
2
Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA. Mohammad.farooq@pennmedicine.upenn.edu.
3
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
4
Department of Pathology, University of Pennsylvania, Philadelphia, PA, USA.
5
Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA, USA.
#
Contributed equally.
PMID:
41062897
DOI:
10.1245/s10434-025-18507-y
No abstract available